Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2021

Mar 27, 2021

35540_dirs_2021-03-26_aa7fdbae-680f-4d2d-9caa-ef66e8cd8baa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2020-10-09

Reporting Person: Gallagher Patrick Joseph (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-10-09 Stock Option (Right to Buy) $5.03 A 50000 Acquired 2030-10-09 Common Stock (50000) Direct

Footnotes

F1: One-third of the shares covered by the option shall vest and become exercisable on October 9, 2021, and the remaining two-thirds of the shares covered by the option shall vest and become exercisable in substantially equal quarterly installments during the two-year period commencing on October 9, 2021, vesting in full on October 9, 2023, subject to continued service through each vest date.